COVID-19 Infection and Myocarditis: A State-of-the-Art Systematic Review
CONCLUSION: It is essential to demarcate COVID-19 infection and myocarditis presentations due to the heightened risk of death among patients contracting both myocardial inflammation and ARDS. With a multitude of diagnostic and treatment options available for COVID-19 and myocarditis, patients that are under high risk of suspicion for COVID-19 induced myocarditis must be appropriately diagnosed and treated to curb co-infections.PMID:34854348 | DOI:10.1177/21501327211056800
Source: Primary Care - Category: Primary Care Authors: Vikash Jaiswal Zouina Sarfraz Azza Sarfraz Dattatreya Mukherjee Nitya Batra Gazala Hitawala Sadia Yaqoob Abhinav Patel Preeti Agarwala None Ruchika Muzna Sarfraz Shehar Bano Nishwa Azeem Sidra Naz Akash Jaiswal Prachi Sharma Gaurav Chaudhary Source Type: research
More News: Azithromycin | Cardiogenic Shock | Cardiology | Cardiovascular | Cough | COVID-19 | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Electrocardiogram | Endocrinology | Heart | Hospital Management | Hypertension | Methylprednisolone | MRI Scan | Myocarditis | Pain | Pain Management | Primary Care | Radiography | Respiratory Medicine | SARS | Science | Zithromax